ROP vs TERN · P/E 41, rev $1.88B vs $6.12B cap
Roper Technologies, Inc. (ROP) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
ROP currently screens at market cap $61.61B and trailing P/E 41.3. TERN currently screens at market cap $6.12B.
Not investment advice. Open the ROP and TERN stock pages for the full models.
Not investment advice.